Lipotoxicity in HepG2 cells triggered by free fatty acids

American Journal of Translational Research

Volumn 3, Issue 3, 2011, Pages 284-291

  Yao, Hong Rui ^a   Liu, Jun ^a   Plumeri, Daniel ^c   Cao, Yong Bing ^b   He, Ting ^a   Lin, Ling ^b   Li, Yu ^b   Jiang, Yuan Ying ^b   Li, Ji ^a,c   Shang, Jing ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

Free fatty acids; HepG2 cells; Lipid accumulation; Lipotoxicity; Nonalcoholic fatty liver disease

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; FATTY ACID; LIPOCORTIN 5;

APOPTOSIS; ARTICLE; CELL STRAIN HEPG2; CELL STRUCTURE; HUMAN; HUMAN CELL; LIPID STORAGE; LIPOTOXICITY; QUANTITATIVE ANALYSIS;

EID: 79957561550     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Mehta K, Van Thiel DH, Shah N and Mobarhan S. Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants. Nutr Rev 2002; 60: 289-293.
2. Farrell GC and Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006; 43: S99-S112.
3. Day CP and James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998; 114: 842-845.
4. Musso G, Gambino R and Cassader M. Recent insights into hepatic lipid metabolism in nonalcoholic fatty liver disease (NAFLD). Prog Lipid Res 2009; 48: 1-26.
5. Grishko V, Rachek L, Musiyenko S, Ledoux SP and Wilson GL. Involvement of mtDNA damage in free fatty acid-induced apoptosis. Free Radic Biol Med 2005; 38: 755-762.
6. Chiu HC, Kovacs A, Ford DA, Hsu FF, Garcia R, Herrero P, Saffitz JE and Schaffer JE. A novel mouse model of lipotoxic cardiomyopathy. J Clin Invest 2001; 107: 813-822.
7. Wu X, Zhang L, Gurley E, Studer E, Shang J, Wang T, Wang C, Yan M, Jiang Z, Hylemon PB, Sanyal AJ, Pandak WM, Jr. and Zhou H. Prevention of free fatty acid-induced hepatic lipotoxicity by 18beta-glycyrrhetinic acid through lysosomal and mitochondrial pathways. Hepatology 2008; 47: 1905-1915.
8. Lin CL, Huang HC and Lin JK. Theaflavins attenuate hepatic lipid accumulation through activating AMPK in human HepG2 cells. J Lipid Res 2007; 48: 2334-2343.
9. Cheng Y, Zhang J, Shang J and Zhang L. Prevention of free fatty acid-induced hepatic lipotoxicity in HepG2 cells by magnesium isoglycyrrhizinate in vitro. Pharmacology 2009; 84: 183-190.
10. Yang L, Zhou X, Yang J, Yin X, Han L and Zhao D. Aspirin inhibits cytotoxicity of prion peptide PrP106-126 to neuronal cells associated with microglia activation in vitro. J Neuroimmunol 2008; 199: 10-17.
11. Malhi H, Bronk SF, Werneburg NW and Gores GJ. Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis. J Biol Chem 2006; 281: 12093-12101.
12. Malhi H, Gores GJ and Lemasters JJ. Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology 2006; 43: S31-44.
13. Pusl T, Wild N, Vennegeerts T, Wimmer R, Goke B, Brand S and Rust C. Free fatty acids sensitize hepatocytes to bile acid-induced apoptosis. Biochem Biophys Res Commun 2008; 371: 441-445.
14. Listenberger LL, Han X, Lewis SE, Cases S, Farese RV, Jr., Ory DS and Schaffer JE. Triglyceride accumulation protects against fatty acidinduced lipotoxicity. Proc Natl Acad Sci U S A 2003; 100: 3077-3082.
15. Eitel K, Staiger H, Brendel MD, Brandhorst D, Bretzel RG, Haring HU and Kellerer M. Different role of saturated and unsaturated fatty acids in beta-cell apoptosis. Biochem Biophys Res Commun 2002; 299: 853-856.
16. Schaffer JE. Lipotoxicity: when tissues overeat. Curr Opin Lipidol 2003; 14: 281-287.
17. Wang C, Jiang Z, Yao J, Wu X, Sun L, Liu C, Duan W, Yan M, Liu J and Zhang L. Participation of cathepsin B in emodin-induced apoptosis in HK-2 Cells. Toxicol Lett 2008; 181: 196-204.
18. Hwang JT, Park IJ, Shin JI, Lee YK, Lee SK, Baik HW, Ha J and Park OJ. Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem Biophys Res Commun 2005; 338: 694-699.